Metformin: update on mechanisms of action on liver diseases

Substantial attention has been paid to the various effects of metformin on liver diseases; the liver is the targeted organ where metformin exerts its antihyperglycemic properties. In non-alcoholic fatty liver disease (NAFLD), studies have shown that metformin affects the ATP/AMP ratio to activate AM...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Gaoyi Ruan, Fangquan Wu, Dibang Shi, Hongxia Sun, Fangyan Wang, Changlong Xu
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2023-12-01
Serier:	Frontiers in Nutrition
Fag:	non-alcoholic liver disease metformin cirrhosis AMPK pathway drug-induced liver injury
Online adgang:	https://www.frontiersin.org/articles/10.3389/fnut.2023.1327814/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!